Evaluation of Newcastle disease virus vaccine effectiveness in dogs with neurological signs of canine distemper
- 1 December 2022
- journal article
- research article
- Vol. 13 (4) , 563-568
Abstract
Canine Distemper Virus (CDV) is the cause of a highly lethal infectious disease affecting a broad range of carnivores. Despite using various treatments, there is still no effective treatment, especially in the neurological form of distemper. The aim of this study was to evaluate the therapeutic effect of injecting Newcastle disease vaccine into the subarachnoid space of dogs with neurological form of distemper. The dogs that had symptoms of nervous distemper, particularly myoclonus, were included in the plan. After anesthetizing of dogs, 0.10 to 1.00 mL of cerebrospinal fluid (CSF) were removed and, 0.10 to 0.50 mL of the prepared Newcastle solution were injected into their subarachnoid space. Another 0.50 to 1.00 mL of normal saline was then injected to remove the needle from the vaccine. The live attenuated LaSota or B1 vaccine was used in this study. Rapid kit tests and reverse transcription polymerase chain reaction (RT-PCR) assays were used to diagnose of the disease. Dogs were monitored for up to 3 to 24 months during that time they were evaluated for improvement or worsening of clinical symptoms. Out of nine dogs in which distemper were diagnosed with different tests, one dog recovered completely and another dog recovered greatly. Therefore, the overall recovery rate was 22.20%. It is concluded that administration of Newcastle vaccine into the subarachnoid space of dogs with nervous distemper causes at least 22.20% improvement and does not cause specific side effects and can be used to treat affected dogs. (c) 2022 Urmia University. All rights reserved.Keywords
This publication has 12 references indexed in Scilit:
- Controversial results of therapy with mesenchymal stem cells in the acute phase of canine distemper diseaseGenetics and Molecular Research, 2016
- Recombinant Newcastle disease viral vector expressing hemagglutinin or fusion of canine distemper virus is safe and immunogenic in minksVaccine, 2015
- New Aspects of the Pathogenesis of Canine Distemper LeukoencephalitisViruses, 2014
- Detection and differentiation of field and vaccine strains of canine distemper virus using reverse transcription followed by nested real time PCR (RT-nqPCR) and RFLP analysisJournal of Virological Methods, 2013
- Pathogenesis and immunopathology of systemic and nervous canine distemperVeterinary Immunology and Immunopathology, 2009
- An immunochromatography assay for rapid antemortem diagnosis of dogs suspected to have canine distemperJournal of Virological Methods, 2008
- Canine Distemper Virus Infection Requires Cholesterol in the Viral EnvelopeJournal of Virology, 2007
- Clinicopathological findings in dogs with distemper encephalomyelitis presented without characteristic signs of the diseaseResearch in Veterinary Science, 2006
- Effect of vaccination with recombinant canine distemper virus vaccine immediately before exposure under shelter-like conditions.2006
- Relation of Clinical Signs to Pathological Changes in 19 Cases of Canine Distemper EncephalomyelitisJournal of Comparative Pathology, 2002